Cancer Family
Urinary System Neoplasm
CI-CAN-00000379Explore in graph →
Non-malignant964 active trials28 approved drugs109 evidence items
- NCIt
- C3431
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000379Explore in graph →
Clinical trials
4,238 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03676946 | A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma | unknown | Phase 1 / Phase 2 | 15 | Lee's Pharmaceutical LimitedINDUSTRY | 1 | Sep 26, 2018 | clinicaltrials |
| NCT03050047 | A Multicenter Open-Label Single-Arm Multi-Cohort Phase I Study of BCD-100 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 15 | BiocadINDUSTRY | 1 | Aug 31, 2018 | clinicaltrials |
| NCT02919371 | Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA) | unknown | Phase 1 / Phase 2 | 77 | King Faisal Specialist Hospital & Research CenterOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT03577132 | The Efficacy of Neoadjuvant Atezolizumab Treatment in Patients With Advanced Urothelial Bladder Cancer | unknown | N/A | 20 | Seoul National University HospitalOTHER | 0 | Jul 31, 2018 | clinicaltrials |
| NCT03062410 | Quality of Life Assessment in Daily Clinical Oncology Practice for Patients With Advanced Renal Cell Carcinoma(QUANARIE) | unknown | N/A | 56 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 26, 2018 | clinicaltrials |
| NCT03597087 | The Difference of Two Year Recurrence Rate According to Anesthetic Method During Transurethral Resection of Bladder Mass in Patients With Non-muscle Invasive Bladder Cancer: Prospective, Randomized, Clinical Phase II Study | unknown | N/A | 289 | Seoul National University HospitalOTHER | 1 | Jul 24, 2018 | clinicaltrials |
| NCT03563443 | Genomic Imprinting Testing for Diagnosis of Bladder Cancer | unknown | — | 300 | Changhai HospitalOTHER | 1 | Jun 20, 2018 | clinicaltrials |
| NCT03341845 | Neoadjuvant AXITINIB and AVELUMAB for Patients With Localized Clear-cell RCC | unknown | Phase 2 | 40 | The Netherlands Cancer InstituteOTHER | 1 | May 21, 2018 | clinicaltrials |
| NCT01809119 | Prospective Randomized Study Comparing Laparoscopic Versus Open Partial Nephrectomy | unknown | N/A | 242 | University of Sao PauloOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT03442647 | Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal Function | unknown | N/A | 30 | Thomas MuellerOTHER | 1 | May 14, 2018 | clinicaltrials |
| NCT02805608 | uPAR PET/CT and FDG PET/MRI for Preoperative Staging of Bladder Cancer | unknown | Phase 2 | 40 | Rigshospitalet, DenmarkOTHER | 1 | Apr 11, 2018 | clinicaltrials |
| NCT03464032 | A Study of BCD-135 in Patients With Advanced Solid Tumors | unknown | Phase 1 | 30 | BiocadINDUSTRY | 1 | Mar 13, 2018 | clinicaltrials |
| NCT02841904 | The Accuracy of Optic Biopsies Versus Conventional Biopsies for the Diagnosis of Superficial Bladder Neoplasia | unknown | N/A | 189 | Herlev HospitalOTHER | 1 | Mar 6, 2018 | clinicaltrials |
| NCT03076372 | A Study Evaluating MM-310 in Patients With Solid Tumors | unknown | Phase 1 | 34 | Merrimack PharmaceuticalsINDUSTRY | 1 | Feb 27, 2018 | clinicaltrials |
| NCT03427034 | Assessment of BladderLight SurvEILlance(ABSEIL) | unknown | Phase 2 / Phase 3 | 2,100 | Cambridge University Hospitals NHS Foundation TrustOTHER | 0 | Feb 9, 2018 | clinicaltrials |
| NCT03409029 | A Study Using MRI To Assess Bladder Motion During Radiotherapy | unknown | N/A | 20 | The Christie NHS Foundation TrustOTHER | 0 | Jan 30, 2018 | clinicaltrials |
| NCT03148158 | Assessment Of Bladder Tumors Stage And Grade By Outpatient Flexible Cystoscopy Performed By Urology Resident | unknown | — | 300 | Mansoura UniversityOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT02072044 | Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs Therapy | unknown | Phase 2 | 60 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd.INDUSTRY | 1 | Dec 29, 2017 | clinicaltrials |
| NCT03209206 | The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder Recurrence | unknown | Phase 2 | 84 | Seoul National University HospitalOTHER | 1 | Dec 22, 2017 | clinicaltrials |
| NCT03347045 | Trimodal Prehabilitation for Cystectomy Patients to Enhance Post-operative Care(TPC-RCT) | unknown | N/A | 50 | Jason MartynOTHER | 0 | Nov 20, 2017 | clinicaltrials |
| NCT03331705 | Assessment of the Uro-C Cystoscope for Use in Diagnostic Cystoscopy Procedures | unknown | — | 30 | UroSee CorporationINDUSTRY | 1 | Nov 6, 2017 | clinicaltrials |
| NCT02886026 | Outpatient PDD Guided Laser Mediated Destruction of Bladder Tumors(LaserIII) | unknown | N/A | 248 | University Hospital Bispebjerg and FrederiksbergOTHER | 1 | Nov 1, 2017 | clinicaltrials |
| NCT02760953 | TURBt With Adjuvant Cryoablation to Treat Bladder Cancer | unknown | N/A | 150 | Huashan HospitalOTHER | 0 | Oct 19, 2017 | clinicaltrials |
| NCT02228330 | Prospective Clinical Trial - Obturator Reflex Predictors and Blockage | unknown | N/A | 50 | Rabin Medical CenterOTHER | 1 | Oct 17, 2017 | clinicaltrials |
| NCT03296306 | Four Cycles Versus Six Cycles of Cisplatin-based Chemotherapy in Metastatic Urothelial Carcinoma(FOCUS) | unknown | Phase 3 | 330 | Asan Medical CenterOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT02740426 | Prophylactic Intravesical Chemotherapy to Prevent Bladder Recurrence After Diagnostic Ureteroscopy for Primary Upper Tract Urothelial Carcinoma Patients | unknown | Phase 2 | 200 | Peking University First HospitalOTHER | 1 | Sep 21, 2017 | clinicaltrials |
| NCT03280459 | Evaluation of Robot-assisted Intracorporeal Urinary Reconstruction(iRARC-KSW) | unknown | — | 200 | Kantonsspital Winterthur KSWOTHER | 1 | Sep 12, 2017 | clinicaltrials |
| NCT03274284 | Chemoradiotherapy for Recurrent T1G3 Bladder Cancer | unknown | Phase 4 | 20 | Assiut UniversityOTHER | 0 | Sep 11, 2017 | clinicaltrials |
| NCT02429440 | Adjuvant Antigen Specific Immunotherapy in Patients With Advanced Renal Cell Carcinoma Using Tumor Associated Peptides(UroRCC) | unknown | Phase 1 / Phase 2 | 40 | University Hospital TuebingenOTHER | 0 | Aug 17, 2017 | clinicaltrials |
| NCT03230201 | Lymph Node Dissection in High-risk UTUC(Upper Tract Urothelial Carcinoma)(UTUC) | unknown | N/A | 80 | Peking University First HospitalOTHER | 1 | Aug 8, 2017 | clinicaltrials |
| NCT03221829 | A Retrospective Analysis of Spinal Anaesthesia for TURBT Procedures in Elderly Patients | unknown | — | 2,800 | Medical University of WarsawOTHER | 1 | Jul 19, 2017 | clinicaltrials |
| NCT02696733 | Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach | unknown | Phase 4 | 100 | Medical University of WarsawOTHER | 1 | Jul 18, 2017 | clinicaltrials |
| NCT03218319 | Study of the Variations of the Blood Pressure After Nephrectomy for Renal Cancer (VAPANCR)(VAPANCR) | unknown | N/A | 200 | University Hospital, AngersOTHER_GOV | 0 | Jul 14, 2017 | clinicaltrials |
| NCT03193788 | Pemetrexed Maintenance in Patients With Urothelial Carcinoma Who Completed First Line Platinum-based Chemotherapy(PREMIER) | unknown | Phase 3 | 74 | Asan Medical CenterOTHER | 1 | Jun 21, 2017 | clinicaltrials |
| NCT03033186 | Everolimus TDM to Predict Long Term Toxicity(Foresight) | unknown | — | 40 | Maastricht University Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT03038321 | Solifenacin, Levofloxacin or Lornoxicam, Which Is Ideal for Management of Intravesical Instillation BCG Side Effects? | unknown | Phase 4 | 150 | Mansoura UniversityOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT03138824 | Storz Professional Image Enhancement System Versus White Light Imaging Assisted TURBT for Treatment of NMIBC | unknown | N/A | 100 | Mansoura UniversityOTHER | 1 | May 23, 2017 | clinicaltrials |
| NCT03138837 | Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage | unknown | — | 385 | Mansoura UniversityOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT03149523 | Exhaustive Genetic and Immunological Characterization of Colon, Kidney and Liver Tumors(ExhauCRF) | unknown | — | 150 | European Georges Pompidou HospitalOTHER | 1 | May 17, 2017 | clinicaltrials |
| NCT03121768 | A New Prognostic Model for Predicting the Outcome of Patients With Non-muscle Invasive Bladder Cancer (NMIBC) | unknown | — | 761 | Mansoura UniversityOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT03147586 | Influence of Immune Nutrition Diet on 90-Day Outcomes in Patients Undergoing Radical Cystectomy | unknown | Phase 4 | 100 | Mansoura UniversityOTHER | 1 | May 10, 2017 | clinicaltrials |
| NCT02330783 | Efficacy and Safety of Bevacizumab Plus Sorafenib for the Third-line Treatment in Metastatic Renal Cancer Patients | unknown | Phase 2 | 106 | Peking University Cancer Hospital & InstituteOTHER | 1 | May 9, 2017 | clinicaltrials |
| NCT01785537 | The Efficacy and Safety of Electronic Cigarettes: a 5-year Follow-up Study | unknown | — | 1,050 | Università degli Studi 'G. d'Annunzio' Chieti e PescaraOTHER | 1 | May 5, 2017 | clinicaltrials |
| NCT03129724 | Retrospective Study in Patients With Metastatic Renal Cancer Treated With TKI Sequence (Tyrosine Kinase Inhibitors of VEGFR) - mTOR- Axitinib Inhibitors or Anti-VEGF Antibody -Inhibiteurs mTOR - Axitinib | unknown | — | 100 | University Hospital, Strasbourg, FranceOTHER | 0 | Apr 26, 2017 | clinicaltrials |
| NCT00184015 | Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC) | unknown | Phase 1 / Phase 2 | 50 | University of Southern CaliforniaOTHER | 1 | Apr 11, 2017 | clinicaltrials |
| NCT03094949 | Comparison Between Partial Nephrectomy and Ablation for Renal Tumor | unknown | N/A | 200 | Chinese PLA General HospitalOTHER | 1 | Mar 29, 2017 | clinicaltrials |
| NCT03047525 | Study of DC-CTL Combined With CIK for Advanced Solid Tumor | unknown | Phase 1 / Phase 2 | 200 | Xiaoyi HuangOTHER | 1 | Feb 9, 2017 | clinicaltrials |
| NCT01099423 | Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer(SURTIME) | unknown | Phase 3 | 99 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Feb 8, 2017 | clinicaltrials |
| NCT03029676 | The Assessment of POCD After TURBT Under Spinal Anesthesia | unknown | Phase 4 | 200 | Medical University of WarsawOTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT02446795 | Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial(QUASAR) | unknown | Phase 1 / Phase 2 | 104 | Consorzio OncotechOTHER | 1 | Jan 18, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Sep 26, 2018source: clinicaltrials